Agilent Brings Expanded PD-L1 Testing and Digital Pathology Workflows to USCAP 2026
The company will highlight a new PD-L1 indication for ovarian cancer and end-to-end digital pathology workflows at the annual meeting in San Antonio.
Latest Articles
Editor's Top Picks
Diabetes Testing Moves Earlier—and Gets More Complex
As the 2026 ADA Standards of Care emphasize earlier identification and more precise classification of diabetes, clinical laboratories are rethinking workflows, assay menus, and their role in detection.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Breath Test Using Carbon Isotopes May Quickly Confirm Bacterial Infections
A proof-of-concept study shows that bacteria-metabolized molecules enriched with carbon-13 produce detectable exhaled CO2, enabling rapid infection identification with inexpensive infrared scanners.
Equipment & Supply Spotlight
Sarstedt’s Tempus1800 Sample Transport System Earns Vizient Innovative Technology Contract
The Vizient Innovative Technology Program evaluates products submitted through client-led councils for their potential to improve clinical care, patient safety, and business operations.
News, Know-How & Standards
Disease Detection & Understanding
ADDF Launches Third Phase of Diagnostics Accelerator with $50 Million to Advance Alzheimer’s Blood Tests and AI Biomarkers
The new funding brings the initiative's total to $150 million and will focus on tau pathology, multi-marker panels, and AI-driven diagnostics.
